303 related articles for article (PubMed ID: 17957481)
1. CD44 adhesion molecule and neuro-glial proteoglycan NG2 as invasive markers of glioma.
Wiranowska M; Ladd S; Smith SR; Gottschall PE
Brain Cell Biol; 2006 Jun; 35(2-3):159-72. PubMed ID: 17957481
[TBL] [Abstract][Full Text] [Related]
2. The effect of interferon and anti-CD44 antibody on mouse glioma invasiveness in vitro.
Wiranowska M; Tresser N; Saporta S
Anticancer Res; 1998; 18(5A):3331-8. PubMed ID: 9858905
[TBL] [Abstract][Full Text] [Related]
3. NG2-cells are not the cell of origin for murine neurofibromatosis-1 (Nf1) optic glioma.
Solga AC; Gianino SM; Gutmann DH
Oncogene; 2014 Jan; 33(3):289-99. PubMed ID: 23318450
[TBL] [Abstract][Full Text] [Related]
4. Expression of the NG2 proteoglycan enhances the growth and metastatic properties of melanoma cells.
Burg MA; Grako KA; Stallcup WB
J Cell Physiol; 1998 Nov; 177(2):299-312. PubMed ID: 9766527
[TBL] [Abstract][Full Text] [Related]
5. NG2 proteoglycan-expressing microglia as multipotent neural progenitors in normal and pathologic brains.
Yokoyama A; Sakamoto A; Kameda K; Imai Y; Tanaka J
Glia; 2006 May; 53(7):754-68. PubMed ID: 16534776
[TBL] [Abstract][Full Text] [Related]
6. Probing the infiltrating character of brain tumors: inhibition of RhoA/ROK-mediated CD44 cell surface shedding from glioma cells by the green tea catechin EGCg.
Annabi B; Bouzeghrane M; Moumdjian R; Moghrabi A; Béliveau R
J Neurochem; 2005 Aug; 94(4):906-16. PubMed ID: 15992376
[TBL] [Abstract][Full Text] [Related]
7. Electrophysiologically "complex" glial cells freshly isolated from the hippocampus are immunopositive for the chondroitin sulfate proteoglycan NG2.
Schools GP; Zhou M; Kimelberg HK
J Neurosci Res; 2003 Sep; 73(6):765-77. PubMed ID: 12949902
[TBL] [Abstract][Full Text] [Related]
8. NG2 precursor cells in neoplasia: functional, histogenesis and therapeutic implications for malignant brain tumours.
Chekenya M; Pilkington GJ
J Neurocytol; 2002; 31(6-7):507-21. PubMed ID: 14501220
[TBL] [Abstract][Full Text] [Related]
9. CD44 in human glioma correlates with histopathological grade and cell migration.
Yoshida T; Matsuda Y; Naito Z; Ishiwata T
Pathol Int; 2012 Jul; 62(7):463-70. PubMed ID: 22726066
[TBL] [Abstract][Full Text] [Related]
10. Contactin is expressed in human astrocytic gliomas and mediates repulsive effects.
Eckerich C; Zapf S; Ulbricht U; Müller S; Fillbrandt R; Westphal M; Lamszus K
Glia; 2006 Jan; 53(1):1-12. PubMed ID: 16078236
[TBL] [Abstract][Full Text] [Related]
11. Morphological, immunocytochemical and flow cytometric in vitro characterisation of a surface-adherent medulloblastoma.
Parker K; Pilkington GJ
Anticancer Res; 2005; 25(6B):3855-63. PubMed ID: 16309171
[TBL] [Abstract][Full Text] [Related]
12. Increase of NG2-positive cells associated with radial glia following traumatic spinal cord injury in adult rats.
Wu D; Shibuya S; Miyamoto O; Itano T; Yamamoto T
J Neurocytol; 2005 Dec; 34(6):459-69. PubMed ID: 16902766
[TBL] [Abstract][Full Text] [Related]
13. NG2 expressed by macrophages and oligodendrocyte precursor cells is dispensable in experimental autoimmune encephalomyelitis.
Moransard M; Dann A; Staszewski O; Fontana A; Prinz M; Suter T
Brain; 2011 May; 134(Pt 5):1315-30. PubMed ID: 21596769
[TBL] [Abstract][Full Text] [Related]
14. CD44 expression and MMP-2 secretion by mouse glioma cells: effect of interferon and anti-CD44 antibody.
Wiranowska M; Rojiani AM; Gottschall PE; Moscinski LC; Johnson J; Saporta S
Anticancer Res; 2000; 20(6B):4301-6. PubMed ID: 11205262
[TBL] [Abstract][Full Text] [Related]
15. The NG2 chondroitin sulfate proteoglycan: role in malignant progression of human brain tumours.
Chekenya M; Rooprai HK; Davies D; Levine JM; Butt AM; Pilkington GJ
Int J Dev Neurosci; 1999; 17(5-6):421-35. PubMed ID: 10571405
[TBL] [Abstract][Full Text] [Related]
16. Expression of the chondroitin sulphate proteoglycan, NG2, in paediatric brain tumors.
Higgins SC; Bolteus AJ; Donovan LK; Hasegawa H; Doey L; Al Sarraj S; King A; Ashkan K; Roncaroli F; Fillmore HL; Pilkington GJ
Anticancer Res; 2014 Dec; 34(12):6919-24. PubMed ID: 25503117
[TBL] [Abstract][Full Text] [Related]
17. The glial precursor proteoglycan, NG2, is expressed on tumour neovasculature by vascular pericytes in human malignant brain tumours.
Chekenya M; Enger PØ; Thorsen F; Tysnes BB; Al-Sarraj S; Read TA; Furmanek T; Mahesparan R; Levine JM; Butt AM; Pilkington GJ; Bjerkvig R
Neuropathol Appl Neurobiol; 2002 Oct; 28(5):367-80. PubMed ID: 12366818
[TBL] [Abstract][Full Text] [Related]
18. Recruited brain tumor-derived mesenchymal stem cells contribute to brain tumor progression.
Behnan J; Isakson P; Joel M; Cilio C; Langmoen IA; Vik-Mo EO; Badn W
Stem Cells; 2014 May; 32(5):1110-23. PubMed ID: 24302539
[TBL] [Abstract][Full Text] [Related]
19. Development and differentiation of glial precursor cells in the rat cerebellum.
Levine JM; Stincone F; Lee YS
Glia; 1993 Apr; 7(4):307-21. PubMed ID: 8320001
[TBL] [Abstract][Full Text] [Related]
20. Prognostic relevance of NG2/CSPG4, CD44 and Ki-67 in patients with glioblastoma.
Tsidulko AY; Kazanskaya GM; Kostromskaya DV; Aidagulova SV; Kiselev RS; Volkov AM; Kobozev VV; Gaitan AS; Krivoshapkin AL; Grigorieva EV
Tumour Biol; 2017 Sep; 39(9):1010428317724282. PubMed ID: 28945172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
